Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Food and Drug Administration [Docket Nos. FDA-2012-M-0712, FDA-2012-M-0713, FDA-2012-M-0734, FDA-2012-M-0735, FDA-2012-M-0814, FDA-2012-M-0833, FDA-2012-M-0893, FDA-2012-M-0965, FDA-2012-M-0968, FDA-2012-M-1011, and FDA-2012-M-1013]
 AGENCY: Food and Drug Administration, HHS.
 ACTION: Notice.
 SUMMARY: The Food and Drug Administration (FDA) is publishing a list of premarket approval applications (PMAs) that have been approved. This list is intended to inform the public of the availability of safety and effectiveness summaries of approved PMAs through the Internet and the Agency's Division of Dockets Management.
 ADDRESSES: Submit written requests for copies of summaries of safety and effectiveness data to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Please cite the appropriate docket number as listed in table 1 of this document when submitting a written request. See the SUPPLEMENTARY INFORMATION section for electronic access to the summaries of safety and effectiveness.
 FOR FURTHER INFORMATION CONTACT: Nicole Wolanski, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 1650, Silver Spring, MD 20993-0002, 301-796-6570.


SUPPLEMENTARY INFORMATION:  I. Background In accordance with sections 515(d)(4) and (e)(2) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. 360e(d)(4) and (e)(2)), notification of an order approving, denying, or withdrawing approval of a PMA will continue to include a notice of opportunity to request review of the order under section 515(g) of the FD&C Act. The 30-day period for requesting reconsideration of an FDA action under § 10.33(b) (21 CFR 10.33(b)) for notices announcing approval of a PMA begins on the day the notice is placed on the Internet. Section 10.33(b) provides that FDA may, for good cause, extend this 30-day period. Reconsideration of a denial or withdrawal of approval of a PMA may be sought only by the applicant; in these cases, the 30-day period will begin when the applicant is notified by FDA in writing of its decision. The regulations provide that FDA publish a quarterly list of available safety and effectiveness summaries of PMA approvals and denials that were announced during that quarter. The following is a list of approved PMAs for which summaries of safety and effectiveness were placed on the Internet from July 1, 2012, through September 30, 2012. There were no denial actions during this period. The list provides the manufacturer's name, the product's generic name or the trade name, and the approval date. Table 1—List of Safety and Effectiveness Summaries for Approved PMAs Made Available From July 1, 2012, Through September 30, 2012
PMA No., Docket No.
Applicant
Trade name
Approval dateP980022/S010, FDA-2012-M-0965
Medtronic MiniMed, Inc
Guardian Telemetered Glucose Monitoring System (TGMS)
January 7, 2004.P000008/S017, FDA-2012-M-1013
Allergan, Inc
LAP-BAND TM
                             Adjustable Gastric Banding System
February 16, 2011.P100049, FDA-2012-M-0893
Torax Medical, Inc
LINX TM
                             Reflux Management System
March 22, 2012.P010031/S232, FDA-2012-M-0814
Medtronic, Inc
Concerto/Concerto II; Consulta; Maximo II; and Protecta/Protecta XT Families of CRT-Ds
April 4, 2012.( print page 951)P080030, FDA-2012-M-0712
Glaukos Corp
Glaukos iStent® Trabecular Micro-Bypass Stent and Inserter
June 25, 2012.P110007, FDA-2012-M-0734
Abbott Medical Optics, Inc
Healon® EndoCoat OpViscosurgical Ophthalmic Device (OVD) (3% Sodium Hyaluronate)
July 2, 2012.P110037, FDA-2012-M-0713
Roche Molecular Systems, Inc
COBAS® AmpliPrep/COBAS® TaqMan® CMV Test
July 5, 2012.P110030, FDA-2012-M-0735
QIAGEN Manchester, Ltd
*therascreen*
                            ® KRAS RGQ PCR Kit
July 6, 2012.P110043, FDA-2012-M-0833
Abbott Vascular
Omnilink Elite Vascular Balloon-Expandable Stent System
July 31, 2012.P040024/S056, FDA-2012-M-0968
Medicis Aesthetics Holdings, Inc
Restylane L Injectable Gel
August 30, 2012.P110006, FDA-2012-M-1011
U-Systems, Inc
somo-v® Automated Breast Ultrasound System (ABUS)
September 18, 2012
 II. Electronic Access Persons with access to the Internet may obtain the documents at 
                    *http://www.fda.gov/​MedicalDevices/​ProductsandMedicalProcedures/​DeviceApprovalsandClearances/​PMAApprovals/​default.htm.* Dated: December 31, 2012. Leslie Kux, Assistant Commissioner for Policy.


[FR Doc. 2013-00004 Filed 1-4-13; 8:45 am] BILLING CODE 4160-01-P